Proactive - Interviews for investors

Proactive
  • 4.5 (2)
  • INVESTING
  • UPDATED DAILY

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

  1. 1H AGO

    Standard Uranium completes successful first drill program in over 40 years at Corvo Project

    Standard Uranium Vice President of Exploration Sean Hillacre joined Steve Darling from Proactive to announce the completion of drilling activities at the company’s Corvo Uranium Project in northeastern Saskatchewan. The inaugural winter drill program was designed to test the Manhattan, Brooklyn, and Tribeca target areas for basement-hosted uranium mineralization. A total of 2,457 metres was drilled across ten holes, with seven intersecting anomalous radioactivity. The project is being advanced under a three-year earn-in option agreement with Aventis Energy. Across the program, multiple intervals of anomalous radioactivity exceeding 300 counts per second were identified, totaling approximately 23 metres of composite mineralization across all intervals. Radioactivity was hosted within pegmatite, paragneiss, and granitoid orthogneiss units, with structural settings including hydrothermally altered fault zones and quartz-carbonate veining—features consistent with uranium mineral systems in the region. Multiple structural corridors remain open along strike. Geochemical assays from drill core samples are currently pending. Hillacre noted that several priority uranium targets remain along more than 25 kilometres of untested strike length. Additional surface exploration and a second-phase drill program are being planned to follow up on the radioactive intervals and further evaluate regional targets across the project. Importantly, this marks the first drilling at Corvo in more than 40 years, with results confirming critical metal fertility across multiple target areas. Standard Uranium and Aventis Energy will incorporate the findings into their broader exploration strategy as they advance basement-hosted uranium targets across the project. #proactiveinvestors #standarduraniumltd #tsxv #stnd #otcqb #sttdf #mining #uranium #SeanHillacre #CorvoProject #UraniumExploration #SaskatchewanMining #AthabascaBasin #CriticalMinerals #DrillingResults #BasementHosted #Radioactivity #MineralExploration #AventisEnergy #ExplorationUpdate #Geology #ResourceDevelopment #NuclearFuel

    6 min

  2. 6H AGO

    Amerant ETF targets high-yield Latin American bonds without currency risk

    Amerant Investments Chief Investment Officer Baylor Lancaster-Samuel joined Steve Darling from Proactive to discuss the Amerant Latin American Debt UCITS ETF (RNTA), outlining how the fund offers investors targeted exposure to high-yield Latin American corporate bonds while eliminating currency risk. Lancaster-Samuel said the ETF was designed to solve a common challenge for investors seeking access to the region’s fixed income markets. Many Latin American corporate bonds are issued in large minimum denominations, making it difficult for individual and smaller institutional investors to build diversified portfolios. By packaging these opportunities into an ETF structure, RNTA provides more accessible and efficient exposure to the asset class. The fund invests in U.S. dollar-denominated corporate bonds, allowing investors to benefit from emerging market yields without being exposed to foreign exchange volatility. Lancaster-Samuel emphasized that this approach enables the ETF to focus on high-quality issuers across Latin America, particularly large, well-established companies with international operations. Geographically, RNTA is concentrated in key regional economies including Brazil, Mexico, and Colombia, while maintaining diversification across roughly 50 issuers. The portfolio spans a wide range of sectors such as metals and mining, oil and gas, utilities, financial services, retail, agriculture, and technology, providing balanced exposure across the region’s economic landscape. One of the ETF’s most compelling features is its yield profile. Lancaster-Samuel highlighted that yields in Latin America can reach approximately 6.6%, notably higher than those available in broader emerging markets or U.S. fixed income benchmarks. He added that the fund’s yield to worst is approaching 8%, positioning RNTA as an attractive option for income-focused investors seeking both yield and potential capital appreciation. Importantly, the ETF avoids sovereign debt entirely, instead concentrating on corporate issuers where stronger yield opportunities and more targeted credit selection can be achieved. #proactiveinvestors #hanetf #amerantinvestments #BaylorLancaster-Samuel #ETF #FixedIncome #LatinAmerica #EmergingMarkets #Investing #Yield #Bonds #UCITS #IncomeInvesting #USDBonds #AssetManagement #InvestmentStrategy #FinancialMarkets #WealthManagement

    5 min

  3. 6H AGO

    Volta Metals boosts visibility with OTCQB listing after Springer update

    Volta Metals CEO Kerem Usenmez joined Steve Darling from Proactive’s OTC studio in New York City to discuss the company’s latest developments, including its new OTCQB listing and a resource update from its Springer Rare Earth Element project in Ontario. The company, which is focused on rare earths, gallium, lithium, cesium, and tantalum, is advancing a portfolio of critical minerals projects across Ontario through its Volta, Springer, and Aki properties—located in one of the world’s most active emerging hard-rock critical mineral districts. Usenmez announced that Volta’s common shares have begun trading on the OTCQB Venture Market under the ticker “VOLMF,” providing increased visibility and accessibility for U.S. investors. The company will continue to trade on the Canadian Securities Exchange under the symbol “VLTA.” The OTCQB listing is expected to broaden the shareholder base and improve liquidity as Volta advances its flagship Springer Rare Earth Element and Gallium Project. He also highlighted a recently completed independent NI 43-101 Mineral Resource Estimate, which confirms Springer as one of the largest rare earth element deposits in North America. Key highlights include a 1,248% increase in Indicated Resources to 56.6 million tonnes at 0.70% total rare earth oxides (TREO), including a high-grade near-surface core of 11.5 million tonnes at 1.10% TREO. Inferred Resources increased by 841% to 119.5 million tonnes at 0.58% TREO, including a near-surface high-grade core of 3 million tonnes at 1.16% TREO. The company also noted that gallium results from the Fall 2025 drill program have not yet been included in the current estimate, with additional assays expected. Volta is now advancing toward a Preliminary Economic Assessment (PEA), supported by a planned 5,000-metre Phase 2 drill program and ongoing metallurgical testing, with completion targeted for the end of 2026. The updated resource includes significant concentrations of neodymium, praseodymium, dysprosium, and terbium, further reinforcing Springer’s strategic importance in the critical minerals supply chain. #proactiveinvestors #voltametals #cse #vlta #otcqb #volmf #CriticalMinerals #RareEarths #Gallium #Lithium #Cesium #Tantalum #OntarioMining #SpringerProject #REE #OTCQB #VOLMF #CSE #MineralResources #PEA

    6 min

  4. 6H AGO

    BioVie targets neuroinflammation and insulin resistance in Parkinson’s treatment approach

    BioVie CEO Cuong Do joined Steve Darling from Proactive to discuss the company’s novel approach to treating Parkinson’s disease, focusing on neuroinflammation and insulin resistance as key drivers of the condition. Do challenged the traditional view of Parkinson’s as solely a dopamine-related disorder, explaining that inflammation in the brain may play a more fundamental role. He noted that insulin resistance can impair the ability of brain cells to access glucose, stating, “If you have inflammation, the inflammation acts like rust on that lock… and therefore the door stays closed and glucose cannot get in.” This lack of energy in neurons may contribute significantly to disease progression. BioVie’s lead drug candidate, Bezisterim, is designed to target these underlying mechanisms. According to Do, clinical trials have shown that patients receiving the therapy experienced reductions in neuroinflammation along with improvements in insulin sensitivity. Earlier studies combining Bezisterim with Levodopa also demonstrated enhanced muscle control compared to standard treatment alone. The company is now advancing a new clinical trial evaluating Bezisterim as a standalone therapy in early-stage Parkinson’s patients. The study is designed to assess both motor and non-motor symptoms, including sleep, anxiety, and depression. With enrollment now complete, BioVie is targeting a topline data readout before the end of June, marking an important near-term catalyst for the program. proactiveinvestors #biovieince #nasdaq #bivi #NeurodegenerativeDiseases #parkinsonsdisease #BrainHealth #BioVie #CognitionImprovement #Neuroinflammation #SocialImpact #ElderlyCare #Neuroscience #HealthCrisis #DementiaSupport #BrainScience #GlobalHealth #InsulinResistance #Biotech #DrugDevelopment #ClinicalTrials #Bezisterim #CNSResearch #Neuroscience #HealthcareInnovation #MedicalResearch #Biopharma #Neurodegeneration #ToplineData

    5 min

  5. 6H AGO

    Silver Range expands Drum project in Utah and advances exploration plans

    Silver Range Resources CEO Mike Power joined Steve Darling from Proactive to provide an update on the company’s Drum Project in central Utah, highlighting a significant expansion of its land position. Power explained that Silver Range has increased the project footprint from 7 to 37 Federal Lode Claims through additional staking. The newly acquired ground includes the Rattler Breccia and other prospective showings located south of the core mineralized zones. In addition to expanding the land package, the company has acquired a comprehensive set of historical exploration data from previous operators, including Gold Fields Exploration, Newmont, Renaissance Gold Corp., and Troymet Exploration Corp. This dataset includes geological, geochemical, geophysical, and drilling information, which is now being compiled and analyzed to support upcoming exploration programs later this year. The Drum Property, located in Juab County, hosts gold mineralization within widespread jasperoid replacement zones and breccias developed in Cambrian Orr Formation limestone. Power noted that the geological setting, mineralization style, and geochemical signature are comparable to Carlin-type deposits found in neighboring Nevada. Initial sampling conducted by Silver Range has returned encouraging results, with gold values ranging from trace up to 1.02 grams per tonne and silver values from trace up to 15.2 grams per tonne across 23 chip samples. The company is now advancing its understanding of the project as it prepares for the next phase of exploration. #proactiveinvestors #silverrangeresources #tsxv #sng #mining #mikepower #nevada #DrumProject #UtahMining #GoldExploration #SilverExploration #MineralExploration #MiningClaims #CarlinType #Geology #Geophysics #Geochemistry #ResourceDevelopment #ExplorationUpdate #JuniorMining #MiningGrowth

    5 min

  6. 10H AGO

    IXICO CEO on growth, margins & TechBio strategy

    IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) CEO Bram Goorden joined Proactive's Stephen Gunnion to discuss a strong first half, with revenues up 23% to £3.9 million and gross margin expanding to 53%. Growth has been driven by new contract wins, extensions and rising demand for analytics across late-stage Alzheimer's, Parkinson's and rare CNS trials. The order book hit a multi-year high of £18.1 million - up 38% - giving strong visibility on future revenues. Following a £10 million fundraise, IXICO is now pursuing a TechBio strategy, licensing its platform to unlock recurring revenue streams and building strategic partnerships, including a recent collaboration with Medidata. For more insights into IXICO’s growth strategy and future outlook, visit Proactive’s YouTube channel, like this video, subscribe, and turn on notifications so you never miss an update. #IXICO #BramGoorden #BiotechStocks #HealthcareTech #TechBio #ClinicalTrials #AlzheimersResearch #ParkinsonsResearch #CNS #Biomarkers #Medidata #Investing #SmallCapStocks #LifeSciences #StockMarketNews

    6 min

  7. 1D AGO

    Medicus Pharma files Orphan Drug application for SkinJect in rare skin Cancer indication

    Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has submitted an Orphan Drug Designation application to the U.S. Food and Drug Administration for SkinJect® as a treatment for basal cell carcinoma in patients with Gorlin Syndrome. Bokhari explained that the submission represents a strategic expansion of the SkinJect program into a high unmet-need orphan indication, where current treatment options are limited and often require repeated surgical procedures that can lead to cumulative morbidity and disfigurement. Gorlin Syndrome, also known as nevoid basal cell carcinoma syndrome, is a rare inherited disorder typically caused by mutations in the PTCH1 gene. This leads to dysregulation of the Hedgehog signaling pathway and the development of multiple, recurring skin cancers. Patients may develop dozens to more than 1,000 basal cell carcinomas over their lifetime, often beginning in childhood, creating a significant physical and psychological burden. Currently, there are no FDA-approved therapies specifically for basal cell carcinoma in patients with Gorlin Syndrome, with treatment largely reliant on surgical excision or Mohs surgery. Medicus believes SkinJect® could address this gap through a localized, repeatable, and non-surgical approach. The therapy is a doxorubicin-based dissolvable microneedle array designed for direct intradermal delivery into basal cell carcinoma lesions, targeting tumors at the site while minimizing systemic exposure. The company sees this program as an opportunity to provide a more patient-friendly treatment option for a population with significant unmet medical need. Medicus also noted it has sufficient financial runway into next year to support continued advancement of its clinical programs and key development milestones. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #SkinJect #OrphanDrug #RareDisease #GorlinSyndrome #BasalCellCarcinoma #SkinCancer #Biotech #DrugDevelopment #FDA #Oncology #MedicalInnovation #Healthcare #Microneedle #PatientCare

    6 min

  8. 1D AGO

    Active Energy CEO on fast-tracking grid sites as Ghummud is energised ahead of schedule

    Active Energy Group PLC (AIM:AEG, OTCID:AEUSF) CEO Paul Elliott talked with Proactive's Stephen Gunnion about the company’s rapid progress in energising new sites and building a scalable, cash-generating energy platform. Elliott highlighted the early success of the Ghummud site, which was brought online ahead of schedule, demonstrating the company’s ability to execute efficiently and repeatedly across multiple locations. He explained that this achievement is not a one-off, noting: “We’ve got a clear, repeatable playbook we can now deploy across multiple sites every time,” underlining the company’s confidence in replicating this model as it expands. With current output generating approximately $2.6 million annually from just 5.5 MVA, Active Energy has established a strong unit economics foundation, equating to roughly $1 million per MVA in annual revenue. Elliott detailed how scaling capacity toward 100MW could significantly enhance predictable revenue streams and cash flow, creating what he described as a “compounding flywheel” effect. As additional sites come online, the business is expected to transition into a more substantial cash-generating operation, with future growth increasingly funded internally. He also addressed the key constraints to expansion, including grid readiness and sourcing high-quality connections, while noting that due diligence processes are becoming more streamlined. With a growing pipeline of opportunities already identified, Active Energy is well-positioned to accelerate its rollout strategy. Watch the full interview for insights into Active Energy’s growth trajectory, operational milestones, and long-term scaling strategy. Visit Proactive’s YouTube channel for more videos, like this video, subscribe to the channel, and enable notifications so you never miss an update. #ActiveEnergy #PaulElliott #EnergyInfrastructure #RenewableEnergy #GridConnections #EnergyGrowth #ScalingBusiness #InvestorInsights #CleanEnergy #PowerGeneration #InfrastructureGrowth #EnergyMarkets #ProactiveInvestors

    3 min
See All (601)

Ratings & Reviews

4.5
out of 5
2 Ratings

About

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

Information

You Might Also Like